tiprankstipranks
Advertisement
Advertisement
Pelthos Highlights Infectious Disease Portfolio at Investor Meetings
PremiumCompany AnnouncementsPelthos Highlights Infectious Disease Portfolio at Investor Meetings
1M ago
Pelthos Therapeutics Appoints John M. Gay as CFO
Premium
Company Announcements
Pelthos Therapeutics Appoints John M. Gay as CFO
1M ago
Pelthos Therapeutics says John Gay to succeed Francis Knuettel II as CFO
Premium
The Fly
Pelthos Therapeutics says John Gay to succeed Francis Knuettel II as CFO
1M ago
Pelthos Therapeutics Inc trading halted, volatility trading pause
PremiumThe FlyPelthos Therapeutics Inc trading halted, volatility trading pause
2M ago
Pelthos Therapeutics price target raised to $62 from $60 at Oppenheimer
Premium
The Fly
Pelthos Therapeutics price target raised to $62 from $60 at Oppenheimer
2M ago
Pelthos Highlights 2025 Results and Portfolio Expansion Progress
Premium
Company Announcements
Pelthos Highlights 2025 Results and Portfolio Expansion Progress
2M ago
Pelthos Therapeutics files $200M mixed securities shelf
PremiumThe FlyPelthos Therapeutics files $200M mixed securities shelf
4M ago
Pelthos Therapeutics price target raised to $60 from $57 at Oppenheimer
Premium
The Fly
Pelthos Therapeutics price target raised to $60 from $57 at Oppenheimer
4M ago
Horizon Technology provides $50M loan facility to Pelthos Therapeutics
Premium
The Fly
Horizon Technology provides $50M loan facility to Pelthos Therapeutics
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100